US 12,357,576 · Application 18/216,536 · Granted Jul 15, 2025
US 12,357,576
Formulations of triphenyl calcilytic compounds
Estimated expiration
August 3, 2041
14y 323d remaining
Earliest effective filing
Aug 3, 2021
+ 20 years
Aug 3, 2041
PTA +0d
Aug 3, 2041
No TD
—
Final
Aug 3, 2041
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.
Calculation details
Base term
- Filing date
- June 29, 2023
- Earliest effective filing
- August 3, 2021
- Issue date
- July 15, 2025
- PTA
- 0 days
- Base expiry (before PTA)
- August 3, 2041
August 3, 2021 + 20 years = August 3, 2041
- Continuation of application 17/392,720, filed Aug 3, 2021
- PRO63/061,050 — Provisional — not used for base term
- PRO63/061,050 — Provisional — not used for base term
Terminal disclaimers
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 18/216,536 · US 12,357,576
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 12,357,576: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US12357576Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.